RTX Corp: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Jul 28, 2017 and accepted by EDGAR at Jul 28, 2017, 10:58 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $7.91bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $15.17bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2017-04-01 to 2017-06-30 | $609.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2017-01-01 to 2017-06-30 | $1.19bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-04-01 to 2017-06-30 | $1.54bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2017-01-01 to 2017-06-30 | $3.02bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-04-01 to 2017-06-30 | $2.29bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $4.56bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-04-01 to 2017-06-30 | $226.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $439.0m | us-gaap:InterestExpense |
| Income tax | 3 months2017-04-01 to 2017-06-30 | $532.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | $1.12bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | $1.44bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | $2.83bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | $1.80 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | $3.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | $1.83 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | $3.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 798,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 800,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | $3.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $771.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2017-01-01 to 2017-06-30 | $1.01bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2017-01-01 to 2017-06-30 | $1.37bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-06-30 | $9.35bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $32.83bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $94.79bn | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $23.92bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $64.23bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2017-06-30 | $682.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-06-30 | $28.44bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2017-06-30 | 798,772,783 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-17-000034. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.